EudraCT Number: 2004-002844-93 Sponsor Protocol Number: 6002-INT-001 Start Date: 2005-02-08
Sponsor Name: Kyowa Hakko U.K. Limited
Full Title: A Long-Term, Multicenter, Open-Label Safety Study with Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson’s Disease in Patients with Motor Response Complications on Lev...
Medical condition: Parkinson's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) LV (Completed) GB (Completed) EE (Completed) AT (Completed) IT (Completed) ES (Completed)
Trial results: View results

EudraCT Number: 2004-002076-42 Sponsor Protocol Number: KF5025/11 Start Date: 2006-01-31
Sponsor Name: Grünenthal GmbH [...] 1. Grünenthal GmbH 2. Laboratorios Andrómaco S.A. (co-sponsor Spain)
Full Title: Safety, hemostatic and metabolic effects and contraceptive efficacy of an oral monophasic contraceptive containing 0.03 mg ethinylestradiol and 2 mg chlormadinone acetate (CG5025) used in two diffe...
Medical condition: Wish for contraception
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: HU (Ongoing) ES (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2004-002086-20 Sponsor Protocol Number: A-94-52120-098 Start Date: 2005-03-09
Sponsor Name: Ipsen Pharma GmbH
Full Title: Open, multicentre study on the equivalent efficacy and safety of Botulinum toxin A (500 Units Dysport®) in the treatment of heterogeneous forms of cervical dystonia
Medical condition: Cervical dystonia (CD), one of the most common forms of focal dystonia, is characterised by an altered head posture, pain in the the neck and shoulder region and hypertrophy of the concerned muscle...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2004-002102-30 Sponsor Protocol Number: CC-5013-MM-012 Start Date: 2005-02-17
Sponsor Name: CELGENE EUROPE LIMITED
Full Title: OPEN-LABEL, SINGLE-ARM STUDY OF THE SAFETY AND EFFICACY OF CC-5013 MONOTHERAPY FOR SUBJECTS WITH MULTIPLE MYELOMA A COMPANION STUDY FOR STUDIES THAL-MM-003, CC-5013-MM-009, AND CC-5013-MM-010
Medical condition: Multiple Myeloma
Disease: Version SOC Term Classification Code Term Level
9.1 10028228 Multiple myeloma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-002103-32 Sponsor Protocol Number: 50-03B Start Date: 2005-03-02
Sponsor Name: GELA-Recherche Clinique
Full Title: Phase III multicentre open-label randomised study of ICE plus Rituximab (R-ICE) versus DHAP plus Rituximab (R-DHAP) in previously treated patients with CD 20 positive diffuse large B-cell lymphoma,...
Medical condition: CD 20 positive diffuse large B cell lymphoma
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: IE (Completed)
Trial results: View results

EudraCT Number: 2004-004106-25 Sponsor Protocol Number: EOP 1011E Start Date: 2005-03-31
Sponsor Name: (OSI) Eyetech, Inc
Full Title: A Phase II randomised, dose-ranging, double-masked, multi-center trial, in parallel groups, to determine the safety, efficacy and pharmacokinetics of intravitreous injections of pegaptanib sodium c...
Medical condition: Exudative Age Related Macular Degeneration (AMD)
Disease: Version SOC Term Classification Code Term Level
8 10025411 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-004113-42 Sponsor Protocol Number: P03069 Start Date: 2005-06-07
Sponsor Name: Schering Plough Research Institute
Full Title: SCH 486757 vs Codeine and Placebo in Subjects with Persistent Postviral Cough
Medical condition: Postviral cough
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Prematurely Ended)
Trial results: View results

EudraCT Number: 2004-002172-42 Sponsor Protocol Number: Bay 38-9456/11336 Start Date: 2005-02-09
Sponsor Name: Bayer Oy
Full Title: A randomized, double-blind, double-dummy, multi-center, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediatel...
Medical condition: Erektiohäiriö
Disease: Version SOC Term Classification Code Term Level
10061461
Population Age: Adults Gender: Male
Trial protocol: FI (Completed) SE (Completed) DE (Completed) AT (Completed) GB (Completed) IT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-000086-35 Sponsor Protocol Number: NN304-1430 Start Date: 2004-11-01
Sponsor Name: Novo Nordisk Farma Oy
Full Title: A one-year, multi-national, open-labelled, parallel-group, 2:1 randomised treat-to-target trial comparing efficacy and safety of insulin detemir with insulin glargine using a basal-bolus regimen wi...
Medical condition: Type 1 diabetes
Disease: Version SOC Term Classification Code Term Level
7.0 10012608 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) SE (Completed)
Trial results: View results

EudraCT Number: 2004-000106-41 Sponsor Protocol Number: CXA100750 Start Date: 2004-09-07
Sponsor Name: GlaxoSmithKline Research & Development Ltd
Full Title: A study to investigate the effect of GW406381 on methotrexate pharmacokinetics in patients treated with methotrexate for rheumatoid arthritis
Medical condition: The patients entering the trial have rheumatoid arthritis although treatment of the disease itself is not under investigation in this study.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results